Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study.

Andersen CL, Tesfa D, Siersma VD, Sandholdt H, Hasselbalch H, Bjerrum OW, Felding P, Lind B, Olivarius NF, Palmblad J.

J Intern Med. 2016 Jan 21. doi: 10.1111/joim.12467. [Epub ahead of print]

PMID:
26791682
2.

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.

Ørntoft MB, Nielsen HJ, Ørntoft TF, Andersen CL; Danish Study Group on Early Detection of Colorectal Cancer.

BMC Cancer. 2015 Oct 29;15:819. doi: 10.1186/s12885-015-1832-6.

3.

Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome.

Andersen CL, Nielsen HM, Kristensen LS, Søgaard A, Vikeså J, Jønson L, Nielsen FC, Hasselbalch H, Bjerrum OW, Punj V, Grønbæk K.

Oncotarget. 2015 Dec 1;6(38):40588-97. doi: 10.18632/oncotarget.5845.

4.

Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?

Andersen CL, Eskelund CW, Siersma VD, Felding P, Lind B, Palmblad J, Bjerrum OW, Friis S, Hasselbalch HC, de Fine Olivarius N.

Gynecol Oncol. 2015 Nov;139(2):312-8. doi: 10.1016/j.ygyno.2015.09.017. Epub 2015 Sep 25. No abstract available.

PMID:
26407478
5.

A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms.

Brochmann N, Zwisler AD, Kjerholt M, Flachs EM, Hasselbalch HC, Andersen CL.

Qual Life Res. 2015 Sep 11. [Epub ahead of print]

PMID:
26358064
6.

Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges.

Boisen MM, Andersen CL, Sreekumar S, Stern AM, Oesterreich S.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:322-33. doi: 10.1016/j.mce.2015.04.035. Epub 2015 Aug 11.

PMID:
26276546
7.

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.

Lin X, Stenvang J, Rasmussen MH, Zhu S, Jensen NF, Tarpgaard LS, Yang G, Belling K, Andersen CL, Li J, Bolund L, Brünner N.

BMC Genomics. 2015 May 22;16:404. doi: 10.1186/s12864-015-1552-y.

8.

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS.

Ugeskr Laeger. 2015 May 4;177(19). pii: V12140652. Danish.

PMID:
25967090
9.

3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Kondelin J, Tuupanen S, Gylfe AE, Aavikko M, Renkonen-Sinisalo L, Järvinen H, Böhm J, Mecklin JP, Andersen CL, Vahteristo P, Pitkänen E, Aaltonen LA.

Fam Cancer. 2015 Sep;14(3):449-53. doi: 10.1007/s10689-015-9804-1.

PMID:
25930744
10.

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM.

Mol Oncol. 2015 Jun;9(6):1169-85. doi: 10.1016/j.molonc.2015.02.008. Epub 2015 Feb 24.

PMID:
25759163
11.

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Reinert T, Schøler LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Ørntoft TF, Andersen CL.

Gut. 2015 Feb 4. pii: gutjnl-2014-308859. doi: 10.1136/gutjnl-2014-308859. [Epub ahead of print]

PMID:
25654990
12.

Association of the blood eosinophil count with hematological malignancies and mortality.

Andersen CL, Siersma VD, Hasselbalch HC, Vestergaard H, Mesa R, Felding P, Olivarius ND, Bjerrum OW.

Am J Hematol. 2015 Mar;90(3):225-9. doi: 10.1002/ajh.23916. Epub 2015 Jan 16.

PMID:
25488524
13.

Determinants of recurrence after intended curative resection for colorectal cancer.

Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O, Nielsen KT, Andersen CL, Nielsen HJ.

Scand J Gastroenterol. 2014 Dec;49(12):1399-408. doi: 10.3109/00365521.2014.926981. Epub 2014 Nov 5. Review.

PMID:
25370351
14.

[Screening methods for colorectal cancer can be improved.]

Rasmussen L, Jørgensen LN, Madsen MR, Vilandt J, Klærke M, Andersen J, Nielsen KT, Khalid A, Laurberg S, Andersen CL, Christensen IJ, Brünner N, Nielsen HJ.

Ugeskr Laeger. 2014 Mar 10;176(11B). pii: V09130545. Danish.

PMID:
25350810
15.

Similar strength of the NH···O and NH···S hydrogen bonds in binary complexes.

Andersen CL, Jensen CS, Mackeprang K, Du L, Jørgensen S, Kjaergaard HG.

J Phys Chem A. 2014 Nov 20;118(46):11074-82. doi: 10.1021/jp5086679. Epub 2014 Nov 10.

PMID:
25340722
16.

A dual program for translation regulation in cellular proliferation and differentiation.

Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, Christophersen NS, Christensen LL, Borre M, Sørensen KD, Andersen LD, Andersen CL, Hulleman E, Wurdinger T, Ralfkiær E, Helin K, Grønbæk K, Orntoft T, Waszak SM, Dahan O, Pedersen JS, Lund AH, Pilpel Y.

Cell. 2014 Sep 11;158(6):1281-92. doi: 10.1016/j.cell.2014.08.011.

17.

Identification of 33 candidate oncogenes by screening for base-specific mutations.

Tuupanen S, Hänninen UA, Kondelin J, von Nandelstadh P, Cajuso T, Gylfe AE, Katainen R, Tanskanen T, Ristolainen H, Böhm J, Mecklin JP, Järvinen H, Renkonen-Sinisalo L, Andersen CL, Taipale M, Taipale J, Vahteristo P, Lehti K, Pitkänen E, Aaltonen LA.

Br J Cancer. 2014 Oct 14;111(8):1657-62. doi: 10.1038/bjc.2014.429. Epub 2014 Aug 12.

18.

Putative cis-regulatory drivers in colorectal cancer.

Ongen H, Andersen CL, Bramsen JB, Oster B, Rasmussen MH, Ferreira PG, Sandoval J, Vidal E, Whiffin N, Planchon A, Padioleau I, Bielser D, Romano L, Tomlinson I, Houlston RS, Esteller M, Orntoft TF, Dermitzakis ET.

Nature. 2014 Aug 7;512(7512):87-90. doi: 10.1038/nature13602. Epub 2014 Jul 23.

PMID:
25079323
19.

The Copenhagen Primary Care Differential Count (CopDiff) database.

Andersen CL, Siersma VD, Karlslund W, Hasselbalch HC, Felding P, Bjerrum OW, de Fine Olivarius N.

Clin Epidemiol. 2014 Jun 12;6:199-211. doi: 10.2147/CLEP.S60991. eCollection 2014.

20.

Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.

Andersen CL, Lindegaard H, Vestergaard H, Siersma VD, Hasselbalch HC, de Fine Olivarius N, Bjerrum OW, Junker P.

PLoS One. 2014 Jun 10;9(6):e99388. doi: 10.1371/journal.pone.0099388. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk